Many investors tend to punt on penny stocks to have gains over a near-to medium term, while some penny stocks may also be based on a long-term return profile depending on the stage the company is at. While investing in nascent stage companies is not without risk, some exposure may help build up gains as per stipulated time frame and portfolio development.
Great Boulder Resources Limited (ASX: GBR), a resources group, has been able to successfully raise $2.5 million before costs via a share placement at 27c per share. Over the Eastern Mafic complex to map bedrock geochemistry and determine areas of elevated copper, nickel and cobalt, Great Boulder completed a 226-hole aircore drilling program. Great Boulder routinely checked end of hole and 4m downhole composites with a portable XRF to provide live geochemical data. GRB traded at a market price of $0.380 (July 31, 2018) and the stock has seen a performance change of 272.73% over the past 12 months period.
Telix Pharmaceuticals Limited (ASX: TLX) under health care sector traded at a market price of $0.640 (as at July 31, 2018). The company has seen a performance change of 14.3% in six months but down 7% in last one month. The company has made significant progress over the last quarter with TLX101 (Brain Cancer) for which phase I/II therapeutic trial was successfully submitted in EU, TLX250 (Kidney Cancer) for which Phase III imaging bridging study is recruiting on track (4/10 patients) and expected to complete end-Q3 and TLX591 (Prostrate Cancer) for which successful FDA review of Drug Master File (DMF) for prostate imaging agent and manufacturing is progressing well.
iSignthis Limited (ASX: ISX), an information technology stock was trading at a market price of $0.205, as at July 31, 2018. The company has seen a performance change of 19.44% over the past 12 months. It is a global leader in RegTech and transactional banking/payments. Now, tier 1 infrastructure implementation will be by the inhouse iSignthis software development team. To reduce reliance on incumbent banks and legacy networks, the Company commenced execution of its Australian strategy. Year on year revenues grew 208.91% from $443.88k to $1.37 million while net income improved from a loss of $9.24 million to a lesser loss of $5.70 million.
Gage Roads Brewing Co Limited (ASX: GRB), a brewing company, traded at a market price of $0.110 (as at July 31, 2018), and the stock has seen a performance change of 139.13% over the past 12 months. The company has $2.9 million cash generated from operations during the latest quarter, Q4 FY18. Sales to independent retailers was up by 173% while Gage Roads draught sales is up by 145%. The company has recently announced acquisition of Matso’s Broome Brewing for a transaction value of $12.53 million and was announced on June 8, 2018. It has also successfully completed $10 million placement and $2 million SPP. The sales of Gage Roads’ brands comprise 39% of overall sales mix which is up from 32% in FY17. During the second year of the 5-Year proprietary brand strategy, Gage Roads continued to deliver on key leading indicators.
Oncosil Medical Limited (ASX: OSL), is a medical device company based out of Sydney and focusing on oncology. The stock traded at a market price of $0.210 (as at July 31, 2018) and has seen a performance change of 150% over the past 12 months. For pancreatic cancer, the company is commercializing a break through implantation radiation treatment; and is targeting more than $2bn market opportunity to improve standard of care. Manufacturing and logistics optimized for supply of commercial quantities. U.S. FDA-approved IDE in place and safety run-in is underway, EU regulatory approval, CE Marking is expected in near-term. The group has a highly experienced management team; strong clinical and commercial pedigree.
DigitalX Ltd (ASX: DCC), a block-chain or cryptocurrency based group lately traded at a market price of $0.145 (as at July 31, 2018) and has seen a performance change of staggering 400% over the past 12 months. The company has a total cash of US$ 5.3 million and digital assets trading on exchanges of approximately US$5 million as at quarter ending March 31, 2018. DigitalX appointed corporate advisors to multiple ICO’s in major global markets, while Digitalx is appointed by Bitfinex as a Crypto asset listing advisor. Post the quarter end, DigitalX has also secured mandates for the ICOs. However, the stock is prone to witness movement with changing sentiments on cryptocurrency and was down 10% during early trade on August 01, 2018.
Angel Seafood Holdings Limited (ASX: AS1) is an aquaculture company that traded at a market price of $0.135 (as at July 31, 2018) and has seen a performance change of -9.38% since its inception. It would sell 40,000Doz for the last two quarters of the financial year as was announced by the company in March 2018. The Company has achieved over 71,800Doz for this period which is an 80% jump in anticipated sales and has come at an average price close to 84-cents/oyster. For its newly purchased facility in Port Lincoln, the Company achieved Export Status. An increase in its available debt facilities with the NAB was recently announced by the company.
BrainChip Holdings Ltd (ASX: BRN), which has technological development of design segment on SNAP i.e. spiking neuron adaptive processor, traded at a market price of $0.155 as at July 31, 2018. The company has seen a performance change of -8.82% over the past 12 months. Recently, announced by BrainChip Holdings Ltd. which is a leading neuromorphic computing company is the availability of the Akida Development Environment. Public safety, transportation, agricultural productivity, financial security, cybersecurity and healthcare are some of the applications that have been highlighted to benefit from the Akida solution. BrainChip had also recently announced, as the director of North American end user sales, the appointment of James Roe. The company has been listed locally to further develop its general purpose neural processing unit.
Emeco Holdings Ltd. (ASX: EHL), the industrials sector company providing heavy earth moving equipment rental solutions to contactors and mining companies, traded at a market price of $0.350 as at July 31, 2018. The company has seen a performance change of 153.76% over the past 12 months. The company has seen its share to triple in the past 12 months primarily. Emeco increased its 4Q 2018 operating EBITDA margins to 41.4% up by 90bps on 3Q18, generating operating EBITDA of A$45.0 million, up by 10% on 3Q18. At the end of the fourth quarter, the ramp up of new projects has increased operating utilization. For 2018, financial year reduced net debt / pro forma run rate operating EBITDA to 2.0x. The company’s most recent acquisition was of Matilda Equipment Holdings Pty. Ltd. and the deal was completed on April 30, 2018.
[pluginops_form template_id=’23834′ ]
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a company’s prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.